Acciones Tauriga Sciences, Inc. Other OTC
Acciones
TAUG
US87669X2053
Farmacéuticos
Ventas 2020 | 0,23 0,22 | Ventas 2021 | 0,29 0,27 | Capitalización | 29,3 M 27,41 M |
---|---|---|---|---|---|
Resultado Neto 2020 | -3 M -2,81 M | Resultado Neto 2021 | -3 M -2,81 M | VE / Ventas 2020 | 15.901.203 x |
Deuda neta 2020 | 373 mil 349 mil | Posición de caja neta 2021 | 1,04 M 972 mil | VE / Ventas 2021 | 99.058.952 x |
P/E ratio 2020 |
-0,87
x | P/E ratio 2021 |
-6,09
x | Empleados | - |
Rendimiento 2020 * |
-
| Rendimiento 2021 |
-
| Flotante | 100 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Seth M. Shaw
CEO | Chief Executive Officer | 45 | 22/08/12 |
Kevin P. Lacey
DFI | Director of Finance/CFO | 55 | 05/07/17 |
Keith A. Aqua
CTO | Chief Tech/Sci/R&D Officer | - | 15/07/20 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
James V. Rosati
BRD | Director/Board Member | 74 | 08/03/21 |
Seth M. Shaw
CEO | Chief Executive Officer | 45 | 22/08/12 |
Director/Board Member | 46 | 08/03/21 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+25,83 % | 661 mil M | |
+27,00 % | 566 mil M | |
-6,76 % | 352 mil M | |
+20,34 % | 332 mil M | |
+3,00 % | 283 mil M | |
+13,09 % | 231 mil M | |
+5,46 % | 200 mil M | |
-9,61 % | 195 mil M | |
-6,26 % | 145 mil M |